Heidel Associated Research Group
Stem Cell Aging/
The group's research interest is the development of myeloid neoplasia during aging of the hematopoietic system. The researchers employ genetically engineered mouse models and RNAi technology to functionally characterize signaling pathways and molecules involved in self-renewal, differentiation and aging of hematopoietic stem cells. Moreover, they aim to identify novel therapeutic targets for clinical therapy of aging associated myeloid cancers.
Florian H. Heidel
Associated Group Leader